Serum cortisol and 17-hydroxyprogesterone interrelation in classic 21-hydroxylase deficiency: is current replacement therapy satisfactory?

Serum cortisol and 17-hydroxyprogesterone interrelation in classic 21-hydroxylase deficiency: is current replacement therapy satisfactory?

One of the main aims in the management of patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency is to achieve adequate suppression of the adrenal cortex with the smallest possible dose of glucocorticoid substitution. To evaluate the administration schedule of current replacem...

Ausführliche Beschreibung

Bibliographische Detailangaben
Hauptverfasser:	Charmandari, E, Matthews, D, Johnston, A, Brook, C, Hindmarsh, P
Format:	Journal article
Sprache:	English
Veröffentlicht:	2001

Ähnliche Einträge

Sexual dimorphism in the synchrony of joint growth hormone and cortisol dynamics in children with classic 21-hydroxylase deficiency.
von: Charmandari, E, et al.
Veröffentlicht: (2003)

Oral hydrocortisone administration in children with classic 21-hydroxylase deficiency leads to more synchronous joint GH and cortisol secretion.
von: Charmandari, E, et al.
Veröffentlicht: (2002)

Adrenal adenoma secreting 17-hydroxyprogesterone mimicking non-classical 21-hydroxylase deficiency
von: Beata Woźniak, et al.
Veröffentlicht: (2024-11-01)

First Morning Pregnanetriol and 17-Hydroxyprogesterone Correlated Significantly in 21-Hydroxylase Deficiency
von: Tomoyo Itonaga, et al.
Veröffentlicht: (2022-01-01)

Measurement of 17-Hydroxyprogesterone by LCMSMS Improves Newborn Screening for CAH Due to 21-Hydroxylase Deficiency in New Zealand
von: Mark R de Hora, et al.
Veröffentlicht: (2020-01-01)

Deconvolution analysis of 24-h serum cortisol profiles informs the amount and distribution of hydrocortisone replacement therapy.
von: Peters, C, et al.
Veröffentlicht: (2013)

Cortisol, progesterone, 17α-hydroxyprogesterone, and TSH responses in dogs injected with low-dose lipopolysaccharide
von: Nicole L.B. Corder-Ramos, et al.
Veröffentlicht: (2019-08-01)

Current and future perspectives on clinical management of classic 21-hydroxylase deficiency
von: Analia Yogi, et al.
Veröffentlicht: (2023-10-01)

Method Development and Clinical Utility for Simultaneous Measurement of 21-Deoxycortisol, 17-Hydroxyprogesterone, Cortisol, and Cortisone Levels in Human Plasma Using UHPLC-MS/MS
von: Syed N. Alvi, et al.
Veröffentlicht: (2025-01-01)

21-Hydroxylase deficiency in Brazil
von: T.A.S.S. Bachega, et al.
Veröffentlicht: (2000-10-01)

Dexamethasone application for in vitro fertilisation in non-classic 17-hydroxylase/17,20-lyase-deficient women
von: Xiu-Li Yang, et al.
Veröffentlicht: (2022-10-01)

Joint growth hormone and cortisol spontaneous secretion is more asynchronous in older females than in their male counterparts.
von: Charmandari, E, et al.
Veröffentlicht: (2001)

Effectiveness of 17-Alpha-Hydroxyprogesterone in the Prevention of Preterm Labour
von: Uzma Urooj, et al.
Veröffentlicht: (2023-03-01)

Miscarriages in families with an offspring that have classic congenital adrenal hyperplasia and 21-hydroxylase deficiency
von: Helmuth G. Dörr, et al.
Veröffentlicht: (2018-11-01)

Mortality in children with classic congenital adrenal hyperplasia and 21-hydroxylase deficiency (CAH) in Germany
von: Helmuth G. Dörr, et al.
Veröffentlicht: (2018-06-01)

NON CLASSIC 21 HYDROXYLASE DEFICIENT ADRENAL HYPERPLASIA IN PATIENTS WITH ISOLATED PRECOCIOUS PUBARCHE
von: H. Moayeri, et al.
Veröffentlicht: (2003-09-01)

NON CLASSIC 21 HYDROXYLASE DEFICIENT ADRENAL HYPERPLASIA IN PATIENTS WITH ISOLATED PRECOCIOUS PUBARCHE
von: H. Moayeri, et al.
Veröffentlicht: (2003-07-01)

Co-production of 11α-hydroxyprogesterone and ethanol using recombinant yeast expressing fungal steroid hydroxylases
von: Claire M. Hull, et al.
Veröffentlicht: (2017-09-01)

Adrenal Morphology as an Indicator of Long-Term Disease Control in Adults with Classic 21-Hydroxylase Deficiency
von: Taek Min Kim, et al.
Veröffentlicht: (2022-02-01)

Clinical Profile, Predictors of Death and Anthropometric Follow up in Neonates with Classical 21-Hydroxylase Deficiency
von: Usha Devi Rajendran, et al.
Veröffentlicht: (2018-05-01)

Obesity and Cardiometabolic Risk Factors in Children and Young Adults With Non-classical 21-Hydroxylase Deficiency
von: Liat de Vries, et al.
Veröffentlicht: (2019-10-01)

Flash glucose monitoring system was applied to cortisol treatment for a patient with congenital adrenal hyperplasia and 17α-hydroxylase deficiency
von: Chenyu Xiang, et al.
Veröffentlicht: (2020-09-01)

Production and Scale-Up of a Monoclonal Antibody Against 17-Hydroxyprogesterone
von: Chua, Gek Kee, et al.
Veröffentlicht: (2013)

The Influence of Prior Obstetrical History on Current 17-Hydroxyprogesterone Caproate Use
von: Carla E. Ransom, et al.
Veröffentlicht: (2011-01-01)

An unusual cause of adrenal insufficiency with elevation of 17-hydroxyprogesterone: case report
von: Claudia Teti, et al.
Veröffentlicht: (2023-05-01)

Influence of sample quality on phenylalanine and 17-hydroxyprogesterone levels in neonatal screening
von: Lesley del Río Fabre, et al.

Female pseudohermaphroditism due to classical 21-hydroxylase deficiency and insulin resistance in a girl with Turner syndrome
von: M Emre Atabek, et al.
Veröffentlicht: (2005-04-01)

Comparison of different glucocorticoid regimens in the management of classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency
von: T P Ajish, et al.
Veröffentlicht: (2014-01-01)

Analysis of the Influencing Factors of 17-Hydroxyprogesterone Level and the Correlation between 17-Hydroxyprogesterone Level and the Clinical Parameters Related to Adrenal Cortical Function in Very-Low-Birth-Weight Infants
von: Chang Dae Kum, et al.
Veröffentlicht: (2019-02-01)

Best Practice for Identification of Classical 21-Hydroxylase Deficiency Should Include 21 Deoxycortisol Analysis with Appropriate Isomeric Steroid Separation
von: Ronda F. Greaves, et al.
Veröffentlicht: (2023-10-01)

Mineralocorticoid replacement during infancy for salt wasting congenital adrenal hyperplasia due to 21-hydroxylase deficiency
von: Larissa G. Gomes, et al.
Veröffentlicht: (2013-01-01)

Pharmacogenetics of glucocorticoid replacement could optimize the treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency
von: Ricardo P. P. Moreira, et al.
Veröffentlicht: (2011-01-01)

Functional effects of 17alpha-hydroxyprogesterone caproate (17P) on human myometrial contractility in vitro
von: Morrison John J, et al.
Veröffentlicht: (2004-12-01)

New insights on hyperglycemia in 17-hydroxylase/17,20-lyase deficiency
von: Lingling Xu, et al.
Veröffentlicht: (2022-07-01)

Multiple 17-OHP Cutoff Co-Variates Fail to Improve 21-Hydroxylase Deficiency Screening Accuracy
von: Preet K. Matharu, et al.
Veröffentlicht: (2022-10-01)

Clinical characteristics and treatment during preconception and perinatal period of infertile women with non-classical 21-hydroxylase deficiency
von: Xuejiao Cui, et al.
Veröffentlicht: (2024-10-01)

Impact of glucocorticoid receptor gene polymorphisms on the metabolic profile of adult patients with the classical form of 21-hydroxylase deficiency.
von: Ricardo P P Moreira, et al.
Veröffentlicht: (2012-01-01)

Non-Classical 21-Hydroxylase Deficiency: Analysis of a Mutant Gene in a Uyghur Family and Literature Review
von: Maimaitiming J, et al.
Veröffentlicht: (2021-04-01)

Long-Term Health Outcomes of Korean Adults With Classic Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency
von: Seung Gyun Lim, et al.
Veröffentlicht: (2021-10-01)

Two Adults with Adrenal Myelolipoma and 21-Hydroxylase Deficiency
von: Ingrid Nermoen, et al.
Veröffentlicht: (2009-01-01)